BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakatsuji T, Liu YT, Huang CP, Zouboulis CC, Gallo RL, Huang CM. Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PLoS One 2008;3:e1551. [PMID: 18253498 DOI: 10.1371/journal.pone.0001551] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Ouyang K, Oparaugo N, Nelson AM, Agak GW. T Cell Extracellular Traps: Tipping the Balance Between Skin Health and Disease. Front Immunol 2022;13:900634. [DOI: 10.3389/fimmu.2022.900634] [Reference Citation Analysis]
2 Brüggemann H, Salar-Vidal L, Gollnick HPM, Lood R. A Janus-Faced Bacterium: Host-Beneficial and -Detrimental Roles of Cutibacterium acnes. Front Microbiol 2021;12:673845. [PMID: 34135880 DOI: 10.3389/fmicb.2021.673845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mayslich C, Grange PA, Dupin N. Cutibacterium acnes as an Opportunistic Pathogen: An Update of Its Virulence-Associated Factors. Microorganisms 2021;9:303. [PMID: 33540667 DOI: 10.3390/microorganisms9020303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Zouboulis CC. Endocrinology and immunology of acne: Two sides of the same coin. Exp Dermatol 2020;29:840-59. [DOI: 10.1111/exd.14172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
5 Capoor MN, Birkenmaier C, Wang JC, McDowell A, Ahmed FS, Brüggemann H, Coscia E, Davies DG, Ohrt-Nissen S, Raz A, Ruzicka F, Schmitz JE, Fischetti VA, Slaby O. A review of microscopy-based evidence for the association of Propionibacterium acnes biofilms in degenerative disc disease and other diseased human tissue. Eur Spine J 2019;28:2951-71. [PMID: 31359216 DOI: 10.1007/s00586-019-06086-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
6 Ramasamy S, Barnard E, Dawson TL Jr, Li H. The role of the skin microbiota in acne pathophysiology. Br J Dermatol 2019;181:691-9. [PMID: 31342510 DOI: 10.1111/bjd.18230] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
7 Xu H, Li H. Acne, the Skin Microbiome, and Antibiotic Treatment. Am J Clin Dermatol 2019;20:335-44. [PMID: 30632097 DOI: 10.1007/s40257-018-00417-3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 32] [Article Influence: 19.0] [Reference Citation Analysis]
8 McLaughlin J, Watterson S, Layton AM, Bjourson AJ, Barnard E, McDowell A. Propionibacterium acnes and Acne Vulgaris: New Insights from the Integration of Population Genetic, Multi-Omic, Biochemical and Host-Microbe Studies. Microorganisms 2019;7:E128. [PMID: 31086023 DOI: 10.3390/microorganisms7050128] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
9 Keshari S, Kumar M, Balasubramaniam A, Chang T, Tong Y, Huang C. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes. Expert Review of Vaccines 2019;18:433-7. [DOI: 10.1080/14760584.2019.1593830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Kim MJ, Eun DH, Kim SM, Kim J, Lee WJ. Efficacy of Bacteriophages in Propionibacterium acnes-Induced Inflammation in Mice. Ann Dermatol 2019;31:22-8. [PMID: 33911535 DOI: 10.5021/ad.2019.31.1.22] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Wang Y, Hata TR, Tong YL, Kao M, Zouboulis CC, Gallo RL, Huang C. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines. Journal of Investigative Dermatology 2018;138:2355-64. [DOI: 10.1016/j.jid.2018.05.032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
12 O'Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome 2018;6:177. [PMID: 30285861 DOI: 10.1186/s40168-018-0558-5] [Cited by in Crossref: 74] [Cited by in F6Publishing: 54] [Article Influence: 18.5] [Reference Citation Analysis]
13 Reichenbach T, Kalyani D, Gandini R, Svartström O, Aspeborg H, Divne C. Structural and biochemical characterization of the Cutibacterium acnes exo-β-1,4-mannosidase that targets the N-glycan core of host glycoproteins. PLoS One 2018;13:e0204703. [PMID: 30261037 DOI: 10.1371/journal.pone.0204703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Gharamti AA, Kanafani ZA. Cutibacterium (formerly Propionibacterium) acnes infections associated with implantable devices. Expert Rev Anti Infect Ther 2017;15:1083-94. [PMID: 29125405 DOI: 10.1080/14787210.2017.1404452] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
15 Agak GW, Kao S, Ouyang K, Qin M, Moon D, Butt A, Kim J. Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin. J Invest Dermatol 2018;138:316-24. [PMID: 28864077 DOI: 10.1016/j.jid.2017.07.842] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
16 Zouboulis CC, Dessinioti C, Tsatsou F, Gollnick HPM. Anti-acne drugs in phase 1 and 2 clinical trials. Expert Opin Investig Drugs 2017;26:813-23. [PMID: 28627277 DOI: 10.1080/13543784.2017.1337745] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
17 Lomholt HB, Scholz CFP, Brüggemann H, Tettelin H, Kilian M. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls. Anaerobe 2017;47:57-63. [PMID: 28434779 DOI: 10.1016/j.anaerobe.2017.04.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
18 Liao AH, Hung CR, Lin CF, Lin YC, Chen HK. Treatment effects of lysozyme-shelled microbubbles and ultrasound in inflammatory skin disease. Sci Rep 2017;7:41325. [PMID: 28117399 DOI: 10.1038/srep41325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kwon HH, Suh DH. Recent progress in the research about Propionibacterium acnes strain diversity and acne: pathogen or bystander? Int J Dermatol 2016;55:1196-204. [DOI: 10.1111/ijd.13282] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
20 Suh DH, Kwon HH. What's new in the physiopathology of acne? Br J Dermatol 2015;172 Suppl 1:13-9. [PMID: 25645151 DOI: 10.1111/bjd.13634] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 11.5] [Reference Citation Analysis]
21 Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers 2015;1:15029. [PMID: 27189872 DOI: 10.1038/nrdp.2015.29] [Cited by in Crossref: 114] [Cited by in F6Publishing: 93] [Article Influence: 16.3] [Reference Citation Analysis]
22 Yu Y, Champer J, Kim J. Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes. EuPA Open Proteom 2015;9:1-7. [PMID: 28083470 DOI: 10.1016/j.euprot.2015.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
23 Achermann Y, Goldstein EJ, Coenye T, Shirtliff ME. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev. 2014;27:419-440. [PMID: 24982315 DOI: 10.1128/cmr.00092-13] [Cited by in Crossref: 285] [Cited by in F6Publishing: 115] [Article Influence: 40.7] [Reference Citation Analysis]
24 Achermann Y, Tran B, Kang M, Harro JM, Shirtliff ME. Immunoproteomic Identification of In Vivo-Produced Propionibacterium acnes Proteins in a Rabbit Biofilm Infection Model. Clin Vaccine Immunol 2015;22:467-76. [PMID: 25694647 DOI: 10.1128/CVI.00760-14] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
25 Christensen GJ, Brüggemann H. Bacterial skin commensals and their role as host guardians. Benef Microbes 2014;5:201-15. [PMID: 24322878 DOI: 10.3920/BM2012.0062] [Cited by in Crossref: 134] [Cited by in F6Publishing: 57] [Article Influence: 16.8] [Reference Citation Analysis]
26 Ryu S, Park Y, Kim B, Cho S, Lee J, Lee H, Gurley C, Song K, Johnson A, Armstrong C, Song P. Inhibitory and anti-inflammatory effects of the Helicobacter pylori -derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin. Br J Dermatol 2014;171:1358-67. [DOI: 10.1111/bjd.13480] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
27 Thielitz A, Gollnick H. Overview of new therapeutic developments for acne. Expert Review of Dermatology 2014;4:55-65. [DOI: 10.1586/17469872.4.1.55] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
28 Simonart T. Immunotherapy for acne vulgaris: current status and future directions. Am J Clin Dermatol 2013;14:429-35. [PMID: 24019180 DOI: 10.1007/s40257-013-0042-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
29 Wang Y, Kuo S, Shu M, Yu J, Huang S, Dai A, Two A, Gallo RL, Huang CM. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol 2014;98:411-24. [PMID: 24265031 DOI: 10.1007/s00253-013-5394-8] [Cited by in Crossref: 101] [Cited by in F6Publishing: 87] [Article Influence: 11.2] [Reference Citation Analysis]
30 Mak TN, Schmid M, Brzuszkiewicz E, Zeng G, Meyer R, Sfanos KS, Brinkmann V, Meyer TF, Brüggemann H. Comparative genomics reveals distinct host-interacting traits of three major human-associated propionibacteria. BMC Genomics 2013;14:640. [PMID: 24053623 DOI: 10.1186/1471-2164-14-640] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
31 Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, Dreno B. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol 2014;28:271-8. [PMID: 23905540 DOI: 10.1111/jdv.12224] [Cited by in Crossref: 125] [Cited by in F6Publishing: 110] [Article Influence: 13.9] [Reference Citation Analysis]
32 Wang Y, Zhu W, Shu M, Jiang Y, Gallo RL, Liu YT, Huang CM. The response of human skin commensal bacteria as a reflection of UV radiation: UV-B decreases porphyrin production. PLoS One 2012;7:e47798. [PMID: 23133525 DOI: 10.1371/journal.pone.0047798] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
33 Sharon I, Morowitz MJ, Thomas BC, Costello EK, Relman DA, Banfield JF. Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome Res 2013;23:111-20. [PMID: 22936250 DOI: 10.1101/gr.142315.112] [Cited by in Crossref: 313] [Cited by in F6Publishing: 267] [Article Influence: 31.3] [Reference Citation Analysis]
34 Serroukh Y, Djebara S, Lelubre C, Zouaoui Boudjeltia K, Biston P, Piagnerelli M. Alterations of the Erythrocyte Membrane during Sepsis. Crit Care Res Pract 2012;2012:702956. [PMID: 22675622 DOI: 10.1155/2012/702956] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
35 Perry A, Lambert P. Propionibacterium acnes: infection beyond the skin. Expert Rev Anti Infect Ther 2011;9:1149-56. [PMID: 22114965 DOI: 10.1586/eri.11.137] [Cited by in Crossref: 159] [Cited by in F6Publishing: 130] [Article Influence: 15.9] [Reference Citation Analysis]
36 Popovic S, Urbán E, Lukic M, Conlon JM. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris. Peptides 2012;34:275-82. [PMID: 22374306 DOI: 10.1016/j.peptides.2012.02.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
37 Toyne H, Webber C, Collignon P, Dwan K, Kljakovic M. Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practice. Australas J Dermatol 2012;53:106-11. [PMID: 22571557 DOI: 10.1111/j.1440-0960.2011.00867.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
38 Garbe J, Collin M. Bacterial hydrolysis of host glycoproteins - powerful protein modification and efficient nutrient acquisition. J Innate Immun 2012;4:121-31. [PMID: 22222876 DOI: 10.1159/000334775] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
39 Nakatsuji T, Tang DC, Zhang L, Gallo RL, Huang CM. Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment. PLoS One 2011;6:e14797. [PMID: 21533261 DOI: 10.1371/journal.pone.0014797] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
40 Tzellos T, Zampeli V, Makrantonaki E, Zouboulis CC. Treating acne with antibiotic-resistant bacterial colonization. Expert Opin Pharmacother 2011;12:1233-47. [PMID: 21355786 DOI: 10.1517/14656566.2011.553192] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
41 Liu PF, Nakatsuji T, Zhu W, Gallo RL, Huang CM. Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris. Vaccine 2011;29:3230-8. [PMID: 21354482 DOI: 10.1016/j.vaccine.2011.02.036] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
42 Auffret N. Pathophysiological advances in acne. Annales de Dermatologie et de Vénéréologie 2010;137:6-9. [DOI: 10.1016/s0151-9638(10)70046-6] [Reference Citation Analysis]
43 Auffret N. Avancées physiopathologiques dans l’acné. Annales de Dermatologie et de Vénéréologie 2010;137:S52-6. [DOI: 10.1016/s0151-9638(10)70025-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Lomholt HB, Kilian M. Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS One 2010;5:e12277. [PMID: 20808860 DOI: 10.1371/journal.pone.0012277] [Cited by in Crossref: 168] [Cited by in F6Publishing: 152] [Article Influence: 14.0] [Reference Citation Analysis]
45 Kim S, Oh D, Kwon O, Kang HA. Identification and functional characterization of the NanH extracellular sialidase from Corynebacterium diphtheriae. The Journal of Biochemistry 2010;147:523-33. [DOI: 10.1093/jb/mvp198] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
46 James KA, Burkhart CN, Morrell DS. Emerging drugs for acne. Expert Opin Emerg Drugs 2009;14:649-59. [PMID: 19772370 DOI: 10.1517/14728210903251690] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
47 Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, Huang CM. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 2009;129:2480-8. [PMID: 19387482 DOI: 10.1038/jid.2009.93] [Cited by in Crossref: 185] [Cited by in F6Publishing: 147] [Article Influence: 14.2] [Reference Citation Analysis]
48 Kim J. Acne Vaccines: Therapeutic Option for the Treatment of Acne Vulgaris? Journal of Investigative Dermatology 2008;128:2353-4. [DOI: 10.1038/jid.2008.221] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
49 Tom WL, Barrio VR. New insights into adolescent acne. Current Opinion in Pediatrics 2008;20:436-40. [DOI: 10.1097/mop.0b013e328305e273] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
50 Huang CP, Liu YT, Nakatsuji T, Shi Y, Gallo RR, Lin SB, Huang CM. Proteomics integrated with Escherichia coli vector-based vaccines and antigen microarrays reveals the immunogenicity of a surface sialidase-like protein of Propionibacterium acnes. Proteomics Clin Appl 2008;2:1234-45. [PMID: 21136919 DOI: 10.1002/prca.200780103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
51 Nakatsuji T, Liu YT, Huang CP, Zoubouis CC, Gallo RL, Huang CM. Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J Invest Dermatol 2008;128:2451-7. [PMID: 18463682 DOI: 10.1038/jid.2008.117] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]